Institutional Clinical and Translational Science Award (U54)

The summary for the Institutional Clinical and Translational Science Award (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Institutional Clinical and Translational Science Award (U54): -The ever increasing complexities involved in conducting clinical research are making it more difficult to translate new knowledge to the clinic -- and back again to the bench. These challenges are limiting professional interest in the field and hampering the clinical research enterprise at a time when it should be expanding. -The purpose of this initiative is to assist institutions to create a uniquely transformative, novel, and integrative academic home for Clinical and Translational Science that has the resources to train and advance a cadre of well-trained multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies to promote the application of new knowledge and techniques to patient care. Clinical and Translational Science Awards (CTSAs) will attract basic, translational, and clinical investigators, community clinicians, clinical practices, networks, professional societies, and industry to develop new professional interactions, programs, and research projects. Through innovative advanced degree programs, CTSAs will foster a new discipline of Clinical and Translational Science that will be much broader and deeper than their separate components (definitions of Clinical and Translational Science are provided in Section I.1 of this document). -To succeed, CTSAs will need institutional support and the status of a major administrative entity within the applicant institution, and a Principal Investigator who has authority, perhaps shared with other high-level institutional officials, over requisite space, resources, faculty appointments, protected time, and promotion. NIH anticipates that diverse models will be proposed to fulfill these goals and welcomes innovative proposals that meet the needs of both the local institution and of the wider research community.
Federal Grant Title: Institutional Clinical and Translational Science Award (U54)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-07-007
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.31093.389
CFDA Descriptions: Trans-NIH Research Support 93.389 National Center for Research Resources
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 24, 2007
Posted Date: Mar 22, 2007
Creation Date: Aug 28, 2007
Archive Date: Dec 08, 2007
Total Program Funding: $38,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 8
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Domestic institutions including universities, academic health centers, or other research organizations conducting translational and clinical research are eligible, with the following requirements. Because the Institutional CTSA program is focused on the development of a rigorous and robust academic discipline of clinical and translational science, the applicant institution(s) must include a graduate school accredited to award higher degrees in clinical research. Examples of acceptable higher degrees include M.S. and Ph. D. in topics such as Clinical Research, Public Health, Pharmacology, Nursing and Epidemiology. Partnerships among schools of medicine, dentistry, nursing, pharmacy, osteopathy, public health, engineering and other clinically-related institutions are strongly encouraged, as is the inclusion of other relevant clinical research entities and organizations. The CTSA institution(s) is expected to form an integrated institutional home that includes faculty committed to developing the discipline of clinical and translational science that will transcend multiple departments, schools, clinical and research institutes and hospitals. Therefore, an institution may submit, or be part of, only a single application in response to this RFA. Multiple applications from different divisions, faculties, centers, schools, etc. of the same university or medical school will be returned without further consideration by the NIH. Potential applicants whose existing affiliations will be disrupted by this rule must contact NIH Program Staff to determine whether they may be eligible for a waiver of the restriction on grounds such as the affiliation is supported through active NIH Roadmap Training (T32), Career Development (K12) awards, or long-term affiliations. Foreign institutions are not allowed to apply for this program. Domestic institutions may use CTSA resources to support foreign components activities of projects that receive primary funding from DHHS. Appropriate clearances and approval by NIH program staff are required before the use of CTSA resources begins. These activities are permitted under the U54 component of the CTSA only and may not include K12 or T32 components. Applications from ineligible institutions will not be reviewed. The application must include clear detailed evidence of significant institutional commitment. See announcement for full detail.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Al...
Resource-Related Research Projects for Development of Animal Models and Related Materials ...
Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial R...
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinica...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com